EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Efficacy and Safety of Dry Powder Antibiotics: A Narrative Review

David de la Rosa-Carrillo iD, Guillermo Suárez-Cuartín, Oriol Sibila, Rafael Golpe iD, Rosa-María Girón iD, Miguel-Ángel Martínez-García iD

Journal of Clinical Medicine · 20.05.2023 · 12 (10) · 3577

DOI: 10.3390/jcm12103577 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 20.05.2023. Verfasst von David de la Rosa-Carrillo und 5 weiteren Autor:innen. Beteiligte Einrichtung: Respiratory Department, Hospital de la Santa Creu I Sant Pau, 08041 Barcelona, Spain. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 93 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The use of inhaled antibiotics was initially almost exclusively confined to patients with cystic fibrosis (CF). However, it has been extended in recent decades to patients with non-CF bronchiectasis or chronic obstructive pulmonary disease who present with chronic bronchial infection by potentially pathogenic microorganisms. Inhaled antibiotics reach high concentrations in the area of infection, which enhances their effect and enables their long-term administration to defeat the most resistant infections, while minimizing possible adverse effects. New formulations of inhaled dry powder antibiotics have been developed, providing, among other advantages, faster preparation and administration of the drug, as well as avoiding the requirement to clean nebulization equipment. In this review, we analyze the advantages and disadvantages of the different types of devices that allow the inhalation of antibiotics, especially dry powder inhalers. We describe their general characteristics, the different inhalers on the market and the proper way to use them. We analyze the factors that influence the way in which the dry powder drug reaches the lower airways, as well as aspects of microbiological effectiveness and risks of resistance development. We review the scientific evidence on the use of colistin and tobramycin with this type of device, both in patients with CF and with non-CF bronchiectasis. Finally, we discuss the literature on the development of new dry powder antibiotics.

Schlagwörter

Stichwörter der Autor:innen

Pseudomonas aeruginosaantibioticsbronchiectasischronic bronchial infectioncystic fibrosisdry powder antibioticsinhalation drug

Autor:innen und Institutionen

  • Respiratory Department, Hospital de la Santa Creu I Sant Pau, 08041 Barcelona, Spain.
  • Respiratory Department, Hospital de Bellvitge, 08907 L'Hospitalet de Llobregat, Spain.
  • Respiratory Department, Hospital Clínic i Provincial, 08036 Barcelona, Spain.
  • Respiratory Department, Hospital Lucus Augusti, 27003 Lugo, Spain.
  • Respiratory Department, Hospital de la Princesa, 28006 Madrid, Spain.
  • Respiratory Department, Hospital La Fe, 46026 Valencia, Spain.

ORCID-Profile: David de la Rosa-Carrillo, Rafael Golpe, Rosa-María Girón, Miguel-Ángel Martínez-García

Zitieren

APA

de la Rosa-Carrillo, D., Suárez-Cuartín, G., Sibila, O., Golpe, R., Girón, R. M., & Martínez-García, M. Á. (2023). Efficacy and Safety of Dry Powder Antibiotics: A Narrative Review. Journal of Clinical Medicine, 12(10), 3577. https://doi.org/10.3390/jcm12103577

Vancouver

de la Rosa-Carrillo D, Suárez-Cuartín G, Sibila O, Golpe R, Girón RM, Martínez-García MÁ. Efficacy and Safety of Dry Powder Antibiotics: A Narrative Review. Journal of Clinical Medicine. 2023;12(10):3577. doi:10.3390/jcm12103577

BibTeX
@article{delaRosaCarrillo2023,
  author = {de la Rosa-Carrillo, David and Suárez-Cuartín, Guillermo and Sibila, Oriol and Golpe, Rafael and Girón, Rosa-María and Martínez-García, Miguel-Ángel},
  title = {Efficacy and Safety of Dry Powder Antibiotics: A Narrative Review},
  journal = {Journal of Clinical Medicine},
  year = {2023},
  volume = {12},
  number = {10},
  pages = {3577},
  doi = {10.3390/jcm12103577}
}
Kostenlos starten →